NGNE   $19.19  -1.59% Market Closed After Close 19.19 0.0

Neurogene Inc.
Total Cash 153.90M
totalCashPerShare 11.845
EBITDA -65.47M
Total Debt 13.79M
quickRatio 11.822
currentRatio 12.174
Total Revenue 925.00K
debtToEquity 8.893
Revenue/Share 0.106
ROA -0.32361
ROE -0.41339
grossProfits
freeCashflow -34.07M
operatingCashflow -66.08M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -21.766489
profitMargins 0.0
enterpriseValue 458.50M
forwardPE -10.260579
floatShares 5.08M
sharesOutstanding 12.99M
sharesShort 934.61K
sharesShortPriorMonth 1.79M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.11%
heldPercentInstitutions 1.02%
Short Ratio help_outline 6.53%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 11.934
Price To Book help_outline 3.86
earningsQuarterlyGrowth
netIncomeToCommon 2.36M
trailingEps -3.67%
forwardEps -4.49%
enterpriseToEbitda -7.00
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.22 3Q 2024
institutionsCount 109
lastUpdated Nov. 2, 2024, 6:59 a.m.